The Effect of Analgesia Based Sedation Protocol on Brain Function of Critical Care Patients
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Benzodiazepines is a commonly uesd sedative medication,there are many reports that Benzodiazepines is associated with delirium ,but using of analgesia reduces benzodiazepines requirements .The purpose of this study is to determine whether analgesia based sedation protocol reduces the incident of delirium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2014
CompletedFirst Posted
Study publicly available on registry
March 5, 2014
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedJuly 16, 2014
July 1, 2014
11 months
February 28, 2014
July 15, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence and duration of delirium in patients with different regimens
1 day
Secondary Outcomes (9)
Mortality
28 days
Ventilator-free days
an expected average of 7 days
Mean days of mechanical ventilation
an expected average of 7 days
Length of ICU stay
an expected average of 7 days
Index of anesthesia depth monitoring
From admission to ICU to weaning,about 7 days
- +4 more secondary outcomes
Study Arms (3)
Remifentanil,midazolam
EXPERIMENTALRemifentanil 1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02\~0.1mg/kg/h continuous intravenous pump for 7days or extubation
Fentanyl,midazolam
EXPERIMENTALFentanyl 1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02\~0.1mg/kg/h continuous intravenous pump for 7days or extubation
Normal saline
PLACEBO COMPARATORNormal saline1µg/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02\~0.1mg/kg/h continuous intravenous pump for 7days or extubation
Interventions
Eligibility Criteria
You may qualify if:
- Signing a consent form
- postoperative patient
- Requirement for mechanical ventilation and anticipate time of mechanical ventilation more than 24 hours
- Requirement for sedation
- Age more than 18 and less than 85 years old
You may not qualify if:
- Unstable blood circulation
- Heart rate less than 50 beats per minute
- II ° ~ III ° atrioventricular conduct block
- Intracranial lesions 、neurosurgical intervention and mental disability inability to cooperate;
- Receipt of antipsychotics 、hypnotic drugs before surgery ;
- Alcohol abuse;
- Liver failure class Child-Pugh C;
- Acute Respiratory Distress Syndrome;
- Acute or chronic renal failure;
- Other severe diseases ,septic shock;
- Receipt of neuromuscular blocking drug;
- Pregnancy and nursing woman;
- Allergy to investigational drug or other contraindication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2014
First Posted
March 5, 2014
Study Start
July 1, 2014
Primary Completion
June 1, 2015
Last Updated
July 16, 2014
Record last verified: 2014-07